EMPOWERING
PROTEIN ENGINEERING FOR NEXT GENERATION BIOLOGICS

Site-specific, homogeneous modification of proteins through unique genetic code expansion platform

UNIQUE BIOCONJUGATION PLATFORM

BrickBio's platform technology enables custom tailoring of any protein with homogenous, site-specific and site-selective modifications for research and therapeutic applications and enables novel classes of biologics, including multi-site bispecific antibodies. 

OUR

TECHNOLOGY

PROTEIN ENGINEERING​

 

Improve protein characteristics, such as increasing serum half-life, improved specificity, or boosted activity

BIOCONJUGATION KITS

RUO kits are available for a variety of applications: dye-linked, oligo-linked,

and immuno-based assays

PHARMA PARTNERSHIPS​

Development of custom protein-based therapeutics or research assays to drastically improve R&D productivity

ANTIBODY CONJUGATION

 

Empowering the next generation of ADCs with improved efficacy, dosage, and modification homogeneity

THERAPEUTIC PIPELINE

 

We are currently developing early-stage biologic therapeutic candidates with improved characteristics​

IN VIVO CELL BASED ASSAYS

 

Investigation of protein half-life or protein-protein interactions in vivo with high temporal control 

 

RECENT NEWS

Pipeline

20211016pipelinefig.png
 
 

Careers

Senior Scientist - Cell Line Development

Senior Scientist - Protein Engineering

OUR TEAM

CEO, Co-Founder,

TIGER GENE

VP, COMMERCIAL

DEVELOPMENT

SENIOR ADVISOR &

CHAIRMAN OF SAB

HEAD OF BUSINESS DEVELOPMENT

 
 

CONTACT

BRICKBIO

OUR ADDRESS

12 Gill Street, Suite 4200

Woburn, MA, 01801, USA

For any general inquiries, please fill in the following contact form:

Thanks! We'll be in touch shortly.